hengrui glp-1 Leads Oral GLP-1, Shanghai New Cell Therapy Policy: China biotech Weekly Roundup Kailera's oral GLP-1 asset hits

This study found that people taking GLP-1 medications had a higher chance of developing nonscarring hair loss, says Adam Friedman, MD, a study coauthor and chair of the dermatology department at George Washington University in Washington, DC

This degradation is catalyzed by the ubiquitous serum enzyme dipeptidyl peptidase 4 (DPP-4), which is produced both locally in the intestine and by circulating white blood cells

Learn more about our team and the treatment approaches available for gastroparesis management

An increasing prevalence of glucose metabolism issues among middle-aged and elderly populations underscores the urgent need for effective interventions